Omni 360 Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Omni 360 Wealth's ABBV Position: Q2 2026 in Review
Omni 360 Wealth increased its AbbVie (ABBV) stake by 0.25% in Q2 2026, buying an estimated $1.29K and bringing the position to 2,390 shares worth $602K. The position accounts for 0.28% of the portfolio, ranked #72.
Omni 360 Wealth first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Omni 360 Wealth held 2,390 shares of AbbVie worth $602K as of Q2 2026.
- Omni 360 Wealth bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
- AbbVie made up 0.28% of Omni 360 Wealth's portfolio in Q2 2026, its #72 holding.
- Omni 360 Wealth first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
- 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Omni 360 Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.